APP and Alzheimer disease: The AD-causing mutations in PS1 and PS2 reduce this processive cleavage of APP by the PS1/PS2–γ-secretase complexes (because the mutant presenilin falls off the APP substrate too soon) and therefore increase the likelihood that longer, more hydrophobic Aβ with higher aggregation propensities are produced.